CILcare will exhibit at the ARO 2018

Our team invites you to meet us at the MidWinter meeting of the Association for Research in Otolaryngology on the 10-12 February 2018 at Manchester Grand Hyatt, San Diego, CA. Looking forward to meeting you in San Diego !

CILcare, CBSET, and Draper partner to accelerate hearing loss treatment and care

Industry consortium is dedicated to the translation of novel drug delivery devices for emerging treatments in hearing loss CAMBRIDGE, Mass., Nov. 6, 2017 – CILcare Inc., the world’s leading clinical research organization specializing in ear disorders, and CBSET Inc., a non-profit translational research institute specializing in the advancement of novel […]

SAMP8 as a model of age-related hearing loss now published !

We are pleased to announce that CILcare’s research using SAMP8 (Senescence-accelerated mouse prone 8) as a model of age-related hearing loss (ARHL), is featured in the July 2017 issue of the journal “Neuroscience Letters”. CILcare’s research demonstrates that the SAMP8 strain, which closely mimics human patterns of age-related hearing loss, […]

Gaëlle Naert recently appointed Chief Operations Officer !

CILcare appointed Dr. Gaëlle NAERT as Chief Operations Officer. Gaëlle joined CILcare one year ago with a strong background in Neurosciences, which she has quickly translated into the Hearing and Otic Research. Her keen interest in understanding complex mechanisms has taken her through several aspects of research and project development.  […]

CILcare presenting a poster at the RICT 2017

CILcare will be attending the 53rd International Conference on Medicinal Chemistry (RICT) on July 5-7, 2017, in Toulouse, France. Come and discover our poster explaining the role of the antioxidant NAC (N-Acetyl-L-Cysteine) in age-related hearing loss ! The company will be represented by Dr. Sergio Gonzalez.